---
$id: https://graph.org.ai/products/commodity/51241103
$type: Product
source: UNSPSC
code: "51241103"
title: "Bimatoprost"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bimatoprost

**UNSPSC Code**: 51241103
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue and anti-glaucoma agent with the molecular formula C25H37NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QXS94885MZ, chemically known as 5-heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-n-ethyl-, (1r-(1alpha(z),2beta(1e,3s*),3alpha,5alpha))- but generally known as bimatoprost, which bears US NIH Compound Identifier 5311027. European Medicines Agency schedules Bimatoprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12470MIG. The term BIMATOPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., No. 1.2002, List 47). World Health Organization schedules bimatoprost in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule bimatoprost under HS 29375000 and SITC 54156. As of Q4 2014, BIMATOPROST remains the US FDA Preferred Term for this commodity. Bimatoprost bears US NLM identifiers UMLS ID C0937917 and NCI Concept Code C47414. SMILES: OC1C(C(C(O)C1)/C=C/C(O)CCC1CCCCC1)C/C=C\CCCC(=O)NCC.

